Neukio Biotherapeutics (shanghai) Co., Ltd.
Clinical trials sponsored by Neukio Biotherapeutics (shanghai) Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Engineered immune cells take aim at Hard-to-Treat autoimmune diseases Results expected Jan 2027 (estimated)